List view / Grid view

Type 2 Diabetes

EMA CHMP recommends seven medicines for approval

24 September 2019 | By Victoria Rees (European Pharmaceutical Review)

The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.

news

First oral GLP-1 treatment for type 2 diabetes approved

23 September 2019 | By Rachael Harper (European Pharmaceutical Review)

With the approval of the treatment, Rybelsus, there is a new option for treating type 2 diabetes without injections.

news

NHS releases guidance to remove drugs from prescription list

9 July 2019 | By Victoria Rees (European Pharmaceutical Review)

Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.

news

Type 2 diabetes treatment approved for children and adolescents

18 June 2019 | By Victoria Rees (European Pharmaceutical Review)

The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.

news

Application to EMA filed for the approval of oral semaglutide

29 April 2019 | By European Pharmaceutical Review

It has been announced that a Marketing Authorisation Application (MAA) has been submitted to the European Medicines Agency (EMA) for oral semaglutide.

news

Brilinta shows promise in phase III clinical trial

25 February 2019 | By European Pharmaceutical Review

Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....

news

Canagliflozin may not be associated with fracture risk in diabetes patients

2 January 2019 | By European Pharmaceutical Review

A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...

news

Insulin supply chain transparency needed to prevent price hikes

2 November 2018 | By Iqra Farooq (European Pharmaceutical Review)

The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...

news

Lixisenatide prevents damage to kidneys in diabetes and CVD patients

4 October 2018 | By Iqra Farooq (European Pharmaceutical Review)

Lixisenatide has shown prevention of kidney damage in patients with type 2 diabetes or cardiovascular disease through a study by the EASD...

news

Statins study questions their widespread use in the healthy elderly

11 September 2018 | By Mike Stones

A new observational study has identified no benefit from prescribing statins to healthy pensioners aged over 75 to prevent heart disease...

news

Collaboration to launch for the treatment of type 2 diabetes in China

12 July 2018 | By European Pharmaceutical Review

Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...

news

GDM points toward heightened risk of heart disease

17 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Women who have gestational diabetes mellitus during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future...

news

Interactive app provides disease management tool for diabetes

11 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Scientists have developed an online interactive app to help motivate patients to be more active in managing their disease...

news

Ozempic approved for the treatment of type 2 diabetes

10 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Health Canada has approved Ozempic to improve glycemic control in adults with type 2 diabetes mellitus when metformin is not tolerated or contraindicated...

news

FDA approves Admelog, the first follow-on insulin product to treat diabetes

12 December 2017 | By Dr Zara Kassam (European Pharmaceutical Review)

The FDA has approved Admelog, a short-acting insulin indicated to improve control in blood sugar levels in diabetes...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Type 2 Diabetes